Abstract:3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR) catalyzes the formation of mevalonate. In many classes of organisms, this is the committed step leading to the synthesis of essential compounds, such as cholesterol. However, a high level of cholesterol is an important risk factor for coronary heart disease, for which an effective clinical treatment is to block HMGR using inhibitors like statins. Recently the structures of catalytic portion of human HMGR complexed with six different statins have been determined by a delicate crystallography study (Istvan and Deisenhofer Science 2001, 292, 1160-1164), which established a solid basis of structure and mechanism for the rational design, optimization, and development of even better HMGR inhibitors. In this study, three-dimensional quantitative structure-activity relationship (3D QSAR) with comparative molecular field analysis (CoMFA) was performed on a training set of up to 35 statins and statin-like compounds. Predictive models were established by using two different ways: (1) Models-fit, obtained by SYBYL conventional fit-atom molecular alignment rule, has cross-validated coefficients (q2) up to 0.652 and regression coefficients (r2) up to 0.977. (2) Models-dock, obtained by FlexE by docking compounds into the HMGR active site, has cross-validated coefficients (q2) up to 0.731 and regression coefficients (r2) up to 0.947. These models were further validated by an external testing set of 12 statins and statin-like compounds. Integrated with CoMFA 3D QSAR predictive models, molecular surface property (electrostatic and steric) mapping and structure-based (both ligand and receptor) virtual screening have been employed to explore potential novel hits for the HMGR inhibitors. A representative set of eight new compounds of non-statin-like structures but with high pIC(50) values were sorted out in the present study.

Quantitative Structure–activity Relationship Study on the Inhibitors of Fatty Acid Amide Hydrolase

Structure-based Rational Quest for Potential Novel Inhibitors of Human HMG-CoA Reductase by Combining CoMFA 3D QSAR Modeling and Virtual Screening.

Quantitative Structure Activity Relationship Models For The Prediction Of Rat Lethal Dose 50% Of Aldehydes Based On Heuristic Method And Support Vector Machine

Quantitative prediction of enantioselectivity of Candida antarctica lipase B by combining docking simulations and quantitative structure-activity relationship (QSAR) analysis

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives

Quantitative Structure-Activity Relationships of Antimicrobial Fatty Acids and Derivatives Against Staphylococcus Aureus

CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors

Quantitative Structure-Activity Relationship Study of Amino Acid Derivatives as Histone Deacetylase Inhibitors using the Genetic Algorithm – Multiple Linear Regression

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

3D-QSAR Studies on 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors by Comparative Molecular Field Analysis (Comfa)

Quantitative Structure-Activity Relationship Study of Histone Deacetylase Inhibitors.

Predictive QSAR Models of 3-Acylamino-2-aminopropionic Acid Derivatives As Partial Agonists of the Glycine Site on the NMDA Receptor

Potent and Selective α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase

QSAR study of fiavonoids derivatives as p56lck protein tyrosine kinase inhibitors using GA-SVM

Quantitative Structure-Activity Relationships of Hiv-1 Integrase Inhibitors of Dkas

Three-Dimensional Quantitative Structure-Activity Relationship Analyses of A Series of Butenolide Eta Antagonists

3D-QSAR and Molecular Docking Studies of Hydroxamic Acids As Peptide Deformylase Inhibitors

Three-Dimensional Quantitative Structure−Activity Relationship Analysis of the New Potent Sulfonylureas Using Comparative Molecular Similarity Indices Analysis

Hansch-Type QSAR Models for the Rational Design of MAO Inhibitors: Basic Principles and Methodology

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

Three dimensional quantitative structure-activity relationship of DATA analogues as HIV-1 reverse transcriptase inhibitors